Eris Lifesciences steps in dermatology therapy biz, to buy Oaknet Healthcare for <span class='webrupee'>₹</span>650 cr

[Bilgin]

Eris Lifesciences steps in dermatology therapy biz, to buy Oaknet Healthcare for <span class='webrupee'>₹</span>650 cr For the acquisition, Eris will finance ₹300 crore through internal accruals and ₹350 crore through borrowings. The acquisition will be carried through a share purchase agreement. Post the completion, Oaknet will become a wholly-owned subsidiary of Eris.